These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5914613)
1. [Therapeutic management of arteriosclerosis obliterans of the extremities]. Martorell F Angiologia; 1966; 18(4):155-61. PubMed ID: 5914613 [No Abstract] [Full Text] [Related]
2. [The effectiveness of therapeutic measures in arterial occlusion disease]. Koch A; Klett M; Hild R Dtsch Med J; 1970 May; 21(9):606-22. PubMed ID: 5481584 [No Abstract] [Full Text] [Related]
3. [Use of vasculat in the treatment atherosclerosis obliterans of the extremities]. Politowski M; Zelazny T Przegl Lek; 1965; 21(6):434-6. PubMed ID: 4379214 [No Abstract] [Full Text] [Related]
5. [Current status of the study on the integration of traditional Chinese medicine with Western medicine in the treatment of arteriosclerosis obliterans]. Chen P; Shang D Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Feb; 18(2):122-4. PubMed ID: 11367643 [No Abstract] [Full Text] [Related]
6. [Association of surgical treatment and thrombolytics in acute arterial obliteration of the extremities]. Courbier R Rev Atheroscler (Paris); 1968; 10(2):14-8. PubMed ID: 5759944 [No Abstract] [Full Text] [Related]
7. [Vascular reconstruction in arteriosclerosis obliterans of the lower extremities]. Etai S; Adar R Harefuah; 1980 Aug; 99(3-4):86-8. PubMed ID: 7203217 [No Abstract] [Full Text] [Related]
8. [The management of acute nontraumatic arterial insufficiency]. Bremer JK S Afr J Surg; 1967; 5(4):147-50. PubMed ID: 5600887 [No Abstract] [Full Text] [Related]
9. Surgical management of arteriosclerosis involving the lower extremities. Julian OC; Najafi H Conn Med; 1968 Nov; 32(11):808-13. PubMed ID: 5723979 [No Abstract] [Full Text] [Related]
10. Fibrinolytic activity and the effects of beta-pyridylcarbinol (Ronicol) in patients with arteriosclerosis obliterans. Grodzińska L; Basista M; Kedzior A; Korbut R; Kostka-Trabka E; Gryglewski R Thromb Haemost; 1983 Dec; 50(4):797-9. PubMed ID: 6364447 [TBL] [Abstract][Full Text] [Related]
11. [Effect of conservative treatment on arteriosclerosis obliterans of extremities]. Nowicki S; Tukallo K; Napierala M Pol Przegl Chir; 1965 Jun; 37(6):565-71. PubMed ID: 5835740 [No Abstract] [Full Text] [Related]
12. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities]. Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568 [No Abstract] [Full Text] [Related]
13. [Vasaprostan in everyday practice of vascular surgery department]. Kokhan EP; Pinchuk OV; Batrashov VA Angiol Sosud Khir; 2003; 9(4):127-30. PubMed ID: 14657924 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of temporary disability after reconstructive surgery of the blood vessels of the lower extremities for arteriosclerosis obliterans]. Skliarenko RT Vestn Khir Im I I Grek; 1983 Jul; 131(7):139-41. PubMed ID: 6623818 [No Abstract] [Full Text] [Related]
15. [Lumbar sympathectomy in treating arteriosclerosis obliterans of the arteries of the lower extremities]. Uspenskiĭ LV; Kurguzov OP; Dadvani SA Khirurgiia (Mosk); 1980 Mar; (3):42-7. PubMed ID: 7366096 [No Abstract] [Full Text] [Related]